Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.38 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | PAK4 | O96013 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.38 |
| ▸ | IGF1R | P08069 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.38 |
| ▸ | PRKACA | P17612 | 1/20 | 0.38 |
| ▸ | FLT1 | P17948 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76294 | 0.80 | ALDH1A1 (0.41) | MAP4K4CSF1RFGFR1LTKKDR | |
| SCHEMBL3233813 | 0.79 | HSD17B1 (0.37) | STAT3 | |
| SCHEMBL3245904 | 0.76 | FFAR4 (0.33) | — | |
| SCHEMBL3246195 | 0.73 | GPR84 (0.45) | MAPK14NR4A2ENPP1GCGR | |
| SCHEMBL28314094 | 0.69 | SLC6A4 (0.46) | SLC6A4SLC6A3PTGS2PTGS1GSK3B | |
| SCHEMBL1005911 | 0.69 | SLC6A4 (0.44) | SLC6A4SLC6A3PTGS2PTGS1MAPK14 | |
| SCHEMBL1882609 | 0.68 | L3MBTL1 (0.47) | SLC6A4SLC6A3PTGS2MAPK14FGFR1 | |
| SCHEMBL27649740 | 0.67 | PTGS2 (0.57) | SLC6A4SLC6A3PTGS2PTGS1MAPK14 | |
| SCHEMBL17599648 | 0.67 | SLC6A4 (0.47) | SLC6A4SLC6A3PTGS2PTGS1NR4A2 | |
| SCHEMBL1266377 | 0.67 | ENPP1 (0.45) | SLC6A4SLC6A3PTGS2PTGS1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1225163-B1 | Process for producing isopulegol | TAKASAGO PERFUMERY CO LTD (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-6774269-B2 | CYCLIZATION OF CITRONELLAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20020133046-A1 | Process for producing isopulegol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-1225163-A2 | Process for producing isopulegol | Takasago International Corporation (JP) | 2002-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133046-A1 | Process for producing isopulegol | ACSL3, ACSL1, ACSL6 | SLC6A4 4715/4885SLC6A3 4857/4885PTGS2 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.